Production (Stage)
Milestone Pharmaceuticals Inc.
MIST
$1.73
-$0.01-0.58%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -67.93% | -30.98% | -0.81% | 9.57% | 23.93% |
| Total Depreciation and Amortization | -95.24% | 2,168.00% | -3.85% | -7.14% | -94.74% |
| Total Amortization of Deferred Charges | 5.15% | 2.11% | 4.40% | 4.60% | 3.57% |
| Total Other Non-Cash Items | 28.47% | -21.79% | 1.36% | -6.31% | 6.94% |
| Change in Net Operating Assets | 42.19% | 1,447.60% | -81.56% | 225.47% | -179.00% |
| Cash from Operations | -103.89% | 2.49% | -15.94% | 32.25% | 8.80% |
| Capital Expenditure | 72.73% | -450.00% | 42.86% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 73.53% | 198.47% | -31.66% | 135.13% | -297.08% |
| Cash from Investing | 73.70% | 198.32% | -31.65% | 135.10% | -297.53% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 483.33% | -67.57% | -- | -- | 2,765,400.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | -101.01% | -- |
| Cash from Financing | 483.33% | -67.57% | 124.83% | -100.92% | 3,231,800.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 57.98% | 2,803.02% | -114.79% | 186.28% | -193.51% |